Philotimo Fund, LP - May 14, 2025 SCHEDULE 13G Report for AYTU BIOPHARMA, INC Common Stock, par value $0.0001 per share (AYTU)

Filing Manager
Philotimo Fund, LP
Reporting Manager
Kanen Wealth Management LLC
Security
AYTU BIOPHARMA, INC Common Stock, par value $0.0001 per share
Symbol
AYTU
Shares outstanding
6.16M shares
Disclosed Ownership
382K shares
Ownership
6.2%
Form type
SCHEDULE 13G
Date filed
6/26/2025, 05:01 PM
Date of event
May 14, 2025
Next filing
Jun 26, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Philotimo Fund, LP 4.1% 256K 0 256K /s/ David L. Kanen David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its general partner
Philotimo Focused Growth & Income Fund 2% 126K 0 126K /s/ David L. Kanen David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its investment manager
Kanen Wealth Management LLC 6.2% 382K 0 382K /s/ David L. Kanen David L. Kanen, Managing Member
Kanen David 6.2% 382K 0 382K /s/ David L. Kanen David L. Kanen